This brand name is authorized in Australia, Canada, Cyprus, Estonia, Hong Kong, Lithuania, New Zealand, Poland, Singapore, Turkey, United States, South Africa
The drug ZANTAC contains one active pharmaceutical ingredient (API):
|
1
Ranitidine
UNII BK76465IHM - RANITIDINE HYDROCHLORIDE
|
|
Ranitidine is a specific rapidly acting histamine H2-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion. Ranitidine has a relatively long duration of action and so a single 150 mg dose effectively suppresses gastric acid secretion for twelve hours. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZANTAC Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ZANTAC Injection (Aqueous solution) | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02BA02 | Ranitidine | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1977C, 1978D, 8162N |
| Country: CA | Health Products and Food Branch | Identifier(s): 02230287, 02277301 |
| Country: EE | Ravimiamet | Identifier(s): 1005444, 1005477, 1061525, 1061930, 1061941 |
| Country: HK | Department of Health Drug Office | Identifier(s): 30459, 42045, 42792, 42793 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1062787 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10203, 12270, 13591, 3009 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100072404, 100072410 |
| Country: SG | Health Sciences Authority | Identifier(s): 02428P, 02543P, 12111P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522022359 |
| Country: US | FDA, National Drug Code | Identifier(s): 52565-096, 52565-101, 52565-102 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 28/11.4.3/0437, 28/11.4.3/0438, 28/11.4.3/0439, 30/11.4.3/0040, 35/11.4.3/0341, P/11.4.3/218, S/11.4.3/102, S/11.4.3/378, W/11.4.3/277, Z/11.4.3/303, Z/11.4.3/304 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
